AD/PD™ 2025 is being held April 1-5, 2025, in Vienna, Austria. Details of the poster are as follows: Gain Therapeutics’ lead drug candidate, GT-02287, is in clinical development for the treatment of ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

A new exorcism horror is on the way! After several prominent releases in recent years, and building on the tradition of the cult classic The Exorcist, a new horror flick focusing on the controversial ...

Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the ...